Linda M. Hoover
FDA investigator
Appears on 3 documents from 2009 to 2020, mostly at sites in Pennsylvania. Most often cites production record review (21 CFR 211.192).
- 3
- Documents on file
- 10.5
- Observations per 483
- 2009
- First seen
- 2020
- Most recent
What they cite most
From 21 observations- 21 CFR 211.192Production record review5
- 21 CFR 211.80(a)General requirements3
- 21 CFR 211.110Sampling and testing of in-process materials and drug products2
- 21 CFR 1271.370(a)Labeling1
- 21 CFR 211.105(b)Equipment identification1
- 21 CFR 211.113(b)Control of microbiological contamination1
Activity by year
2009: 1, 2012: 1, 2020: 1
Where
Pennsylvania 2 · Texas 1
Often inspects with
Is Linda M. Hoover coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
3 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2020-02-09 | 483 McNeil Consumer Healthcare, Div OfFeb 9, 2020 · Fort Washington, Pennsylvania | Fort Washington, Pennsylvania | 7 | |
| 2012-04-27 | 483 Celltex Therapeutics CorporationApr 27, 2012 · Sugarland, Texas | Sugarland, Texas | 14 | |
| 2009-06-04 | EIR McNeil Consumer Healthcare, Div of McNeil-PPC, Inc.Jun 4, 2009 · Fort Washington, Pennsylvania | Fort Washington, Pennsylvania | — |
About this profile
What does Linda M. Hoover inspect?
Linda M. Hoover appears on 3 documents on file covering 2 sites, mostly in Pennsylvania.
What do they cite most often?
21 CFR 211.192 (production record review), followed by 21 CFR 211.80(a) and 21 CFR 211.110.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Linda M. Hoover is dated Feb 9, 2020.